Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2005 Nov;43(11):5477-82.
doi: 10.1128/JCM.43.11.5477-5482.2005.

Detection of mutations associated with isoniazid resistance in Mycobacterium tuberculosis isolates from China

Affiliations

Detection of mutations associated with isoniazid resistance in Mycobacterium tuberculosis isolates from China

Min Zhang et al. J Clin Microbiol. 2005 Nov.

Abstract

Nine structural genes (furA, katG, inhA, kasA, Rv0340, iniB, iniA, iniC, and efpA) and two regulatory regions (the oxyR-ahpC intergenic region and the promoter of mabA-inhA) in 87 isoniazid (INH)-monoresistant and 50 INH-susceptible Mycobacterium tuberculosis isolates collected from five provinces of China were analyzed by sequencing. Eighty-two (94.3%) INH-resistant isolates had mutations in the katG gene, with the katG Ser315Thr mutation predominant (55.2%). No mutation at codon 463 of katG was detected among the 50 INH-susceptible isolates with different IS6110 fingerprints. In addition, there were 35 (40.2%) INH-resistant isolates that had a mutation at codon 463 of katG. Of the INH-resistant strains, 20 (23.0%) isolates harbored double mutations at two separate loci of katG. Mutations in the inhA promoter region occurred in 13 (14.9%) isolates; 4.6% of the isolates had inhA structural gene mutations, and 11.5% harbored mutations in the oxyR-ahpC intergenic region. Drug resistance-associated mutations were detected in the iniBAC region and efpA.

PubMed Disclaimer

References

    1. Abate, G., S. E. Hoffner, V. O. Thomsen, and H. Miorner. 2001. Characterization of isoniazid-resistant strains of Mycobacterium tuberculosis on the basis of phenotypic properties and mutations in katG. Eur. J. Clin. Microbiol. Infect. Dis. 20:329-333. - PubMed
    1. Alland, D., I. Kramnik, T. T. Weisbrod, L. Otsubo, R. Cerny, L. P. Miller, W. R. Jacobs, Jr., and B. R. Bloom. 1998. Identification of differentially expressed mRNA in prokaryotic organisms by customized amplification libraries (DECAL): the effect of isoniazid on gene expression in Mycobacterium tuberculosis. Proc. Natl. Acad. Sci. USA 95:13227-13232. - PMC - PubMed
    1. Alland, D., A. J. Steyn, T. Weisbrod, K. Aldrich, and W. R. Jacobs, Jr. 2000. Characterization of the Mycobacterium tuberculosis iniBAC promoter, a promoter that responds to cell wall biosynthesis inhibition. J. Bacteriol. 182:1802-1811. - PMC - PubMed
    1. Bardou, F., C. Raynaud, C. Ramos, M. A. Laneele, and G. Laneele. 1998. Mechanism of isoniazid uptake in Mycobacterium tuberculosis. Microbiology 144:2539-2544. - PubMed
    1. Becerra, M. C., J. Bayona, J. Freeman, P. E. Farmer, and J. Y. Kim. 2000. Redefining MDR-TB transmission-drug resistance “hot spots.” Int. J. Tuber. Lung Dis. 4:387-394. - PubMed

Publication types

LinkOut - more resources